GSA Capital Partners’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-208,776
| Closed | -$246K | – | 2044 |
|
|
2025
Q1 | $246K | Buy |
+208,776
| New | +$246K | 0.02% | 1277 |
|
|
2024
Q3 | – | Sell |
-595,874
| Closed | -$816K | – | 1906 |
|
|
2024
Q2 | $816K | Buy |
+595,874
| New | +$816K | 0.06% | 648 |
|
|
2020
Q2 | – | Sell |
-132,076
| Closed | -$404K | – | 976 |
|
|
2020
Q1 | $404K | Buy |
+132,076
| New | +$404K | 0.1% | 277 |
|
|
2019
Q2 | – | Sell |
-49,403
| Closed | -$357K | – | 1659 |
|
|
2019
Q1 | $357K | Buy |
+49,403
| New | +$357K | 0.04% | 894 |
|
|
2016
Q3 | – | Sell |
-41,800
| Closed | -$294K | – | 1907 |
|
|
2016
Q2 | $294K | Buy |
41,800
+19,384
| +86% | +$136K | 0.02% | 1393 |
|
|
2016
Q1 | $191K | Buy |
22,416
+10,505
| +88% | +$89.5K | 0.01% | 1503 |
|
|
2015
Q4 | $156K | Buy |
+11,911
| New | +$156K | 0.01% | 1689 |
|
|
2015
Q3 | – | Sell |
-176,294
| Closed | -$1.02M | – | 1959 |
|
|
2015
Q2 | $1.02M | Buy |
176,294
+37,311
| +27% | +$215K | 0.04% | 887 |
|
|
2015
Q1 | $812K | Buy |
138,983
+107,367
| +340% | +$627K | 0.03% | 1036 |
|
|
2014
Q4 | $248K | Sell |
31,616
-32,044
| -50% | -$251K | 0.02% | 1370 |
|
|
2014
Q3 | $313K | Buy |
+63,660
| New | +$313K | 0.02% | 1235 |
|